HERV-K (HML-2) envelope-reactive antibodies have also been identified upon SARS-CoV-2 infection in healthy individuals as well as patients with systemic lupus erythematosus (SLE) [39,40]. This evidence concerns the gene CLEC10A and systemic lupus erythematosus.